| Acute abdomen - management in pregnancy
|
| Advanced Maternal Age (AMA) and Outcomes
|
| Antenatal visits provided in the community
|
| Antepartum Haemorrhage
|
| Cholestasis disease in Pregnancy - Diagnosis and Management (SOMANZ)
|
| Corticosteroids - for women at risk of preterm birth or with a fetus at risk of respiratory distress - antenatal - MoHGL2022_006
|
| Early labour assessment in the woman's home
|
| Estimating due date (EDD)
|
| Fetal Growth Assessment (Clinical) in Pregnancy
|
| Fetal Movements - Identification and Management of Reduced Patterns
|
| Group B Streptococcus (GBS) Screening and Prophylaxis
|
| Hepatitis B Positive Mother – Neonatal management
|
| Hepatitis B – Universal Screening in Pregnancy and the Management of a Positive Woman
|
| Hepatitis C Positive Mother – Neonatal Management
|
| High Order Multiple Pregnancy - Antenatal Care
|
| Human Immunodeficiency Virus (HIV) in Pregnancy, Birth and Postpartum period
|
| Hyperemesis Gravidarum and Nausea and Vomiting in Pregnancy - Management
|
| Iron Deficiency, Anaemia and Haemoglobinopathies
|
| Monoamniotic Twins - Management
|
| Next Birth After Ceasarean Section
|
| Parvovirus B19 Screening and Management in Pregnancy
|
| Placenta Praevia/Low-lying Placenta
|
| Prevention of Preterm Birth - progesterone
|
| Referral to Department of Maternal Fetal Medicine (MFM) - Fetal Indications
|
| Refusal - Women who choose to refuse recommended monitoring and treatment in maternity services in SESLHD - SESLHDPR/482
|
| RhD Immunoglobulin (Anti D) - Maternity MoHGL2015_011
|
| Sexually Transmitted Infections (STI) / Blood Born Viruses (BBV) Antenatal Screening and Treatment
|
| Thrombocytopenia in Pregnancy
|
| Thyroid Disease in Pregnancy
|
| Twin Pregnancy – Antenatal Care
|
| Ultrasound at 36 weeks gestation for presentation
|
| Vaginal Swab (High) - Collection
|
